Post-earnings recap
Reported
Thu, Apr 25, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bristol Myers Squibb's earnings report indicates a slight miss on EPS, which contributed to a 2.97% drop in stock price. The lack of revenue data and forward guidance may have raised concerns among investors about the company's near-term performance. The defensive tone from management suggests they are navigating challenges without clear expectations for improvement.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.41 | N/A | -0.73% |
| Revenue | N/A | N/A | N/A |
Management expressed caution regarding future performance without offering specific guidance. They emphasized a focus on their existing product lineup.
Management did not provide specific guidance for the upcoming quarters.
The company is focusing on maintaining its current portfolio amid market challenges.